Quid Pro Quo (QPQ) Tracker
← Back to Influence Map
Entity DossierOrganization

ASTELLAS PHARMA US, INC.

IL · US

Pharmaceutical manufacturer.

pharmaceuticals

Tracked direct giving

$50,000

LDA reported lobbying spend

$7,400,000

Connections

13

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$11.7M
MMMMedicare/Medicaid
$9.9M
CPTCopyright/Patent/Trademark
$9.0M
INSInsurance
$4.7M
TAXTaxation/Internal Revenue Code
$3.6M
PHAPharmacy
$1.2M
BUDBudget/Appropriations
$0

Lobbying Firms Retained

In-house lobbyists (filed as its own registrant)$8.9M
THEGROUP DC, LLC$770K
TARPLIN, DOWNS & YOUNG, LLC$720K
TIBER CREEK GROUP$660K
TODD STRATEGY GROUP$400K
CAPITOL COUNSEL LLC$240K
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)$60K
NVG, LLC$60K
PORTERFIELD, FETTIG & SEARS, LLC$50K
POLICY NAVIGATION GROUP$40K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Donations Given and Outside Spending

Largest 50 records. Rows badged “Spent to support” or “Spent to oppose” are independent expenditures this entity paid to vendors for or against the named candidate. That money was not given to them.

RecipientAmountDateCycle
SENATE LEADERSHIP FUND$50,000Nov 30, 20202020

Relationships

TypeConnected ToDetailsSource
Lobbied onInflation Reduction Act - Energy Provisions (H.R.5376)LDA filing: lobbied on Inflation Reduction Act - Energy, period 1st Quarter (Jan 1 - Mar 31), reported amount $560,000Source
Lobbied onInflation Reduction Act - Drug Pricing Provisions (H.R.5376)LDA filing: lobbied on IRA Drug Pricing Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $560,000Source
RetainedROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)Hired ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) to lobby on NIH March-In RightsSource
RetainedTIBER CREEK GROUPHired TIBER CREEK GROUP to lobby on PharmaceuticalsSource
Lobbied onMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
RetainedCapitol Counsel, LLCHired CAPITOL COUNSEL LLC to lobby on PharmaceuticalsSource
RetainedCAPITOL COUNSEL LLCHired CAPITOL COUNSEL LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
RetainedPORTERFIELD, FETTIG & SEARS, LLCHired PORTERFIELD, FETTIG & SEARS, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
RetainedNVG, LLCHired NVG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
RetainedPOLICY NAVIGATION GROUPHired POLICY NAVIGATION GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
RetainedTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby (2nd Quarter (Apr 1 - June 30) 2024)Source
RetainedTHEGROUP DC, LLCHired THEGROUP DC, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2023)Source
RetainedTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby (3rd Quarter (July 1 - Sep 30) 2024)Source